期刊文献+

结肠癌术后辅助化疗

下载PDF
导出
摘要 结肠癌是临床最常见的恶性肿瘤之一.在美国,结肠癌发病率占所有癌症的第4位,而病死率为第2位.2011年美国约有101340例结肠癌和39870例直肠癌的新发病例;而同年估计将有49380例患者死于结肠癌.我国近年来结肠癌在普通人群中的发病率也有逐渐增高的趋势,达到年均4%.
出处 《中国现代普通外科进展》 CAS 2014年第8期668-670,共3页 Chinese Journal of Current Advances in General Surgery
  • 相关文献

参考文献25

  • 1Jemal A,Siegel R,Xu J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):277-300.
  • 2聂绍发,姚漩,朱桂荣,等武汉市大肠癌危险因素的2:3配比病例对照研究[J].中国公共卫生,2003,29(23):2593-2595.
  • 3何友兼,董秋美,李宇红.结肠癌全身辅助化疗的进展[J].癌症,2005,24(12):1546-1549. 被引量:13
  • 4O'Connell M J,Sargent DJ,Windschitl HE,et al.Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer[J].Clin Colorectal Cancer,2006,6(2):133-139.
  • 5Twelves C,Wong A,Nowacki MP,et al.Capecitabine as adjuvant treatment for stage Ⅲ colon cancer[J].N Engl J Med,2005,352(26):2696-2704.
  • 6Poplin EA,Benedetti JK,Estes NC,et al.Phase Ⅲ Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil,leucovorin and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage Ⅲ and high-risk stage Ⅱ colon cancer[J].J Clin Oncol,2005,23(9):1819-1825.
  • 7Andre T,Boni C,Mounedji-Boudiaf L,et al.Oxaliplatin,fluorouracil and leucovorin as adjuvant treatment for colon cancer[J].N Engl J Med,2004,350 (23):2343-2351.
  • 8Gill S,Loprinzi CL,Sargent DJ,et al.Pooled analysis of fluorouracilbased adjuvant therapy for stage Ⅱ and Ⅲ colon cancer:who benefits and by how much[J].J Clin Oncol,2004,22(10):1797-1806.
  • 9Cascinu S,Catalano V,Piga A,et al.The role of levamisole in the adjuvant treatment of stage Ⅲ colon cancer patients:a randomized trial?of 5-fluorouracil and levamisole versus 5-fluorouracil alone[J].Cancer Invest,2003,21 (5):701-707.
  • 10Andre T,Colin P,Louver C,et al.Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage Ⅱ and Ⅲ colon cancer:results of a randomized trial[J].J Clin Oncol,2003,21 (15):2896-2903.

二级参考文献36

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 2张天泽 徐光炜.肿瘤学[M].天津:天津科学技术出版社,1996.1209.
  • 3汤钊猷.现代肿瘤学[M].上海:上海医科大学出版社,1994.676.
  • 4Buyse M, Zeleniuch-Jacquotte A,Chalmers TC. Adjuvant therapy of colorectal cancer. Why we still don't know? [J]. JAMA, 1988,259(24):3571-3578.
  • 5Wolmark N, Fisher B, Rockette H, et al. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01 [J]. J Natl Cancer Inst, 1988,80( 1 ): 30-36.
  • 6Laurie JA, Moertel CG, Fleming TR,et al. Surgical adjuvant therapy of largebowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic [J]. J Clin Oncol,1989,7(10): 1447-1456.
  • 7Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage Ⅲ colon carcinoma:a final report [J]. Ann Intern Med,1995,122(5) :321-326.
  • 8Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer:results from National Surgical Adjuvant Breast and Bowel Project protocol C-03[J]. J Clin Oncol, 1993,11 (10): 1879-1887.
  • 9O'Connell MJ, Mailliard JA, Kahn MJ,et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer [J]. J Clin Oncol, 1997,15( 1 ) :246-250.
  • 10Efficacy of adjuvant fluorouracil and folinic acid in colon cancer.International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators [J]. Lancet,1995,345 (8955): 939-944.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部